Community Heart and Vascular Hospital has announced that Community Physician Network electrophysiologist, Emily Rose, M.D., is the first in Central Indiana and among the first in the nation to implant a single-chamber implantable cardiac device developed by BIOTRONIK, a leading manufacturer of cardiovascular medical technology.

Last month, the Food and Drug Administration granted final approval for the BIOTRONIK Lumax 740 DX System. The device is a first-in-class ICD that uses a single lead with atrial sensing capabilities. Single-chamber ICDs are sophisticated electronic devices that employ a thin flexible wire, known as a lead, to deliver an electrical shock to the heart when the heart rate becomes dangerously fast.

“While expanding on the benefits of single-chamber ICDs, the new technology provides us with atrial sensing capabilities and home monitoring to keep an eye on important atrial conditions such as A-fib,” Rose said.

The DX System also integrates with BIOTRONIK Home Monitoring, allowing physicians to remotely follow their DX patients’ clinical and device statuses daily at anytime, anywhere in the world. The cellular-based platform can detect clinically relevant events, including silent, asymptomatic arrhythmias and device related issues, allowing for earlier medical intervention.